Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,805,760,478
+$26,514,473 QoQ
Shares Held
7,110,133
-2.3% QoQ
Ownership
0.295%
of shares outstanding
% of Portfolio
4.07%
of 13F equity value
Holder Rank
#39
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Grantham, Mayo, Van Otterloo & Co. LLC holds $3,887,775,493 across 10 Drug Manufacturers - General names. JNJ ranks #1 (46.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
7,110,133 | $1,805,760,478 | |
| 2 | LLY |
ELI LILLY & Co
|
743,966 | $892,335,213 | |
| 3 | MRK |
Merck & Co., Inc.
|
6,785,008 | $871,873,528 | |
| 4 | GSK |
GSK plc
|
3,599,521 | $188,686,890 | |
| 5 | PFE |
Pfizer Inc
|
2,179,317 | $52,477,953 | |
| 6 | NVS |
Novartis AG
|
245,957 | $38,546,381 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
411,483 | $23,709,650 | |
| 8 | SNY |
Sanofi
|
285,165 | $12,165,138 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,805,760,478 | 7,110,133 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,779,246,005 | 7,278,866 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,467,097,316 | 7,089,139 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,263,673,456 | 6,815,195 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,001,189,335 | 6,554,431 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,129,832,596 | 6,812,787 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $919,818,342 | 6,360,243 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,020,011,636 | 6,294,037 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $880,524,257 | 6,024,386 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $763,667,287 | 4,827,532 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $624,822,693 | 3,986,364 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $583,261,477 | 3,744,857 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $556,614,297 | 3,362,822 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $465,002,945 | 3,000,019 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $518,413,871 | 2,934,695 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $490,488,236 | 3,002,499 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $403,606,972 | 2,273,714 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $457,240,993 | 2,579,930 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $437,198,295 | 2,555,669 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $407,105,808 | 2,520,779 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $394,985,730 | 2,397,631 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $385,434,441 | 2,345,205 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $367,286,047 | 2,333,753 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $351,161,022 | 2,358,685 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $319,830,730 | 2,274,271 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $305,120,758 | 2,326,857 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||